Related Experiment Video
Updated: Feb 16, 2026

A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
Opioid Neonatal Abstinence Syndrome: An Overview
Scott L Wexelblatt1, Jennifer M McAllister1, Amy T Nathan1
1Cincinnati Children's Hospital Medical Center, Division of Neonatology, Cincinnati, Ohio, USA.
Neonatal abstinence syndrome (NAS) occurs when infants experience opioid withdrawal after intrauterine opioid exposure. Prompt nonpharmacologic care and standardized weaning protocols can reduce treatment duration and hospital stays for affected infants.
Area of Science:
- Neonatology
- Pharmacology
- Pediatrics
Background:
- Neonatal abstinence syndrome (NAS) is a critical concern in newborns exposed to opioids in utero.
- Early identification of at-risk infants is crucial for timely intervention.
Purpose of the Study:
- To highlight the importance of nonpharmacologic supportive care for infants with NAS.
- To emphasize the role of standardized pharmacologic therapy and opioid weaning protocols.
Main Methods:
- Review of current clinical practices for managing NAS.
- Analysis of the impact of nonpharmacologic and pharmacologic interventions on treatment outcomes.
Main Results:
- Nonpharmacologic supportive care, when initiated early, can effectively manage mild NAS symptoms.
- Stringent opioid weaning protocols are essential for severe cases, aiming to minimize treatment duration.
Conclusions:
- Consistent application of standardized nonpharmacologic approaches is vital for NAS management.
- Well-defined weaning protocols are key to reducing length of stay and pharmacologic treatment for infants with NAS.
Related Concept Videos
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction

